ArticleThe Lancet. Obstetrics, gynaecology, & women's health2025
The WHO Pandemic Agreement: protecting pregnant people.
Abstract read
In one paragraph
Article in The Lancet. Obstetrics, gynaecology, & women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Pradip DashraathDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, National University Health System, Singapore (PD); Division of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA (KN-S); Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Melbourne, VIC, Australia (LH); Mercy Hospital for Women, Melbourne, VIC, Australia (LH); Northern Hospital, Melbourne, VIC, Australia (LH); Murdoch Children's Research Institute, Melbourne, VIC, Australia (LH); Department of Science and Technology, National Research Foundation-Vaccine Preventable Diseases, Medical Research Council, University of the Witwatersrand, Johannesburg, South Africa (SAM); Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa (SAM); Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne 1011, Switzerland (DB).
Karin Nielsen-SainesDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, National University Health System, Singapore (PD); Division of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA (KN-S); Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Melbourne, VIC, Australia (LH); Mercy Hospital for Women, Melbourne, VIC, Australia (LH); Northern Hospital, Melbourne, VIC, Australia (LH); Murdoch Children's Research Institute, Melbourne, VIC, Australia (LH); Department of Science and Technology, National Research Foundation-Vaccine Preventable Diseases, Medical Research Council, University of the Witwatersrand, Johannesburg, South Africa (SAM); Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa (SAM); Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne 1011, Switzerland (DB).
Lisa HuiDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, National University Health System, Singapore (PD); Division of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA (KN-S); Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Melbourne, VIC, Australia (LH); Mercy Hospital for Women, Melbourne, VIC, Australia (LH); Northern Hospital, Melbourne, VIC, Australia (LH); Murdoch Children's Research Institute, Melbourne, VIC, Australia (LH); Department of Science and Technology, National Research Foundation-Vaccine Preventable Diseases, Medical Research Council, University of the Witwatersrand, Johannesburg, South Africa (SAM); Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa (SAM); Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne 1011, Switzerland (DB).
Shabir A MadhiDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, National University Health System, Singapore (PD); Division of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA (KN-S); Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Melbourne, VIC, Australia (LH); Mercy Hospital for Women, Melbourne, VIC, Australia (LH); Northern Hospital, Melbourne, VIC, Australia (LH); Murdoch Children's Research Institute, Melbourne, VIC, Australia (LH); Department of Science and Technology, National Research Foundation-Vaccine Preventable Diseases, Medical Research Council, University of the Witwatersrand, Johannesburg, South Africa (SAM); Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa (SAM); Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne 1011, Switzerland (DB).
David BaudDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, National University Health System, Singapore (PD); Division of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA (KN-S); Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Melbourne, VIC, Australia (LH); Mercy Hospital for Women, Melbourne, VIC, Australia (LH); Northern Hospital, Melbourne, VIC, Australia (LH); Murdoch Children's Research Institute, Melbourne, VIC, Australia (LH); Department of Science and Technology, National Research Foundation-Vaccine Preventable Diseases, Medical Research Council, University of the Witwatersrand, Johannesburg, South Africa (SAM); Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa (SAM); Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne 1011, Switzerland (DB).
Funding
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKVR01AI140718 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHENG, GENHONG, JUNG, JAE U · 2018 to 2022
$3.8MAddressing Evolving Infectious ThreatsT32AI177290 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Risa M. Hoffman, Karin Nielsen · 2023 to 2026
$1.3MInfant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent EpidemicsR56AI172252 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JUNG, JAE U, NIELSEN, KARIN · 2023 to 2023
$370kNIAID NIH HHS R01 AI140718NIAID NIH HHS R56 AI172252NIAID NIH HHS T32 AI177290
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.